Manipal Health IPO Set for Listing After Strong Bidding; Subscription Numbers Signal Investor Interest

Manipal Health IPO Set for Listing After Strong Bidding; Subscription Numbers Signal Investor Interest​

The allotment process for Manipal Health Enterprises' highly anticipated Initial Public Offering (IPO) is expected to be finalized today, August 3. Following a three-day bidding window that concluded on July 31, investors are set to check their allocation status via the official platforms of the BSE and NSE.

Shares of Manipal Health Enterprises are scheduled for listing on both the BSE and NSE markets beginning on August 5. The IPO was priced effectively within a narrow range of Rs 560 to Rs 590 per equity share, attracting significant attention from institutional and retail investors alike.

##IPO Subscription Details and Financial Structure

The entire public issue size amounted to Rs 9,275 crore. Market data available on the National Stock Exchange (NSE) indicates a robust subscription level of 4.92 times by the close of bidding on July 31. This response highlights the market's interest in the healthcare services sector and Manipal Health’s operational scale.

The IPO comprised two parts. A fresh issue of 13.56 crore equity shares aggregated Rs 8,000 crore. This was coupled with an Offer For Sale (OFS) segment comprising 2.16 crore equity shares from existing shareholders, including TPG and Novo Holdings.

##Sectoral Performance Highlights during Bidding

Subscription figures across different investor categories painted a varied picture of demand. The Qualified Institutional Buyers (QIB) portion attracted the highest interest, being subscribed at 8.25 times. Retail Investor (RII) segment also performed well, receiving a subscription rate of 93 percent.

The Non-Institutional Investors (NII) category was booked 1.02 times. This differential in demand among investor types underscores the varied market reception to the offering’s structure and valuation.

##Grey Market Premium Offers Mixed Outlook

While institutional interest remained high, unofficial indicators suggest a potential discount at listing. The latest Grey Market Premium (GMP), tracked by both InvestorGain and IPO Watch, stood at negative Rs 7.

Based on the upper end of the price band (Rs 590), the GMP suggests a likely listing price around Rs 583. This calculation implies a potential discount of nearly 1.2 percent for those who secure allotments. Investors are advised to treat the grey market premium as an unofficial indicator based on market speculation.

##Investor Guidance and Allocation Procedures

Retail investors, who form a significant part of the demand, were required to invest at least Rs 14,750 for a minimum bid of 25 shares, based on the upper price band. The basis of allotment is expected to be finalized today, August 3.

To check their status, applicants can utilize dedicated portals. For BSE, investors must navigate to the IPO allotment page and input their application number or PAN after selecting "Equity" and identifying Manipal Health Enterprises Ltd. For NSE checks, users should visit the official NSE IPO allotment page with the company symbol MANIPALHOS.

##Company Profile and Fund Utilization Plans

Manipal Health Enterprises operates a vast pan-India network of multi-specialty hospitals, clinics, and diagnostic centres. As of March 2026, the company managed 49 hospitals, which encompassed 13,037 licensed beds across 14 states and Union Territories.

The company intends to utilize the proceeds from the fresh issue strategically. Funds are designated for repaying borrowings belonging to its subsidiary, Manipal Hospitals Private Ltd., and acquiring a minority stake in Sahyadri Hospitals Private Ltd., among other general corporate purposes.